Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic test for measuring biochemical changes in the brain. This provides valuable information regarding the brain’s chemistry by using the same resonance phenomenon as MR imaging (MRI). Overview MR Spectroscopy (MRS) can be used alongside a conventional MRI protocol to enable the serial monitoring of biochemical changes. Purpose We can apply MRS to investigate biochemical changes which occur in the early stages of diseases such as stroke, tumours, epilepsy, metabolic disorders, infections and neuro-degenerative diseases. Image Figure 1. T2-weighted image of a patient with a recent right middle cerebral artery territory stroke (hyperintense region on left of image). Image Figure 2. Array of long echo-time spectra (TE=145ms) from the same patient. Note reduced NAA, choline and creatine peaks in the stroke region, and presence of lactate (inverted doublet peak) in several spectra around the medial edge of the lesion. Detail There are two types of spectroscopy techniques. - single voxel spectrospy (SVS) and chemical shift imaging (CSI). The Edinburgh Imaging Facilities - RIE and QMRI, carry out both SVS and CSI techniques. The most commonly measured metabolites are: Creatine (involved in the cellular energy cycle) Choline (a constituent of cell membranes) N-acetyl aspartate (a neuronal marker) Lactate (a by-product of anaerobic metabolism, and thus a marker of ischaemia) Contact Professor Ian Marshall Relevant links What is a MR scan? Stroke Dementia In the news 13 Sep 23. GABA MRS Symposium This article was published on 2024-08-22
